AI-driven life science services and solutions company Saama recently announced the launch of its Tables, Listings, and Figures (TLF) Analyzer — a system that uses Saama’s AI-powered document generation and multi-modal GenAI models to interpret and summarize complex clinical data. This will help to increase workflow efficiency across clinical studies by reducing errors and providing researchers with instant access to and interpretation of study outputs that are based upon the Protocol and Statistical Analysis Plan (SAP).
Saama’s Chief Products and Innovation Officer Prasanna Rao expressed his enthusiasm with this announcement in the company’s press release, stating, “This ability to translate figures into precise, context-rich, clinically relevant narratives gives our customers a distinct competitive advantage by turning one of the most manual, time-consuming steps in [clinical study report] authoring into an instant, insight-driven process. It’s not just faster reporting; it’s smarter, scientifically aligned reporting.”
Founded in 1997 and based out of Campbell, CA, Saama has spent nearly 30 years establishing itself as one of the foremost innovators in the healthcare and life science products and solutions space. The company’s platform made a name for itself by helping to power the clinical trial leading to the world’s first COVID-19 vaccine in 2020, and today it has close to 2,000 employees operating across the United States, Europe, and Asia. For more information on this story, view other related materials below.
See related materials: